Results 41 to 50 of about 87,300 (320)

Bivalirudin started during emergency transport for primary PCI. [PDF]

, 2013
BACKGROUND: Bivalirudin, as compared with heparin and glycoprotein IIb/IIIa inhibitors, has been shown to reduce rates of bleeding and death in patients undergoing primary percutaneous coronary intervention (PCI).
Berg, J. van den, Bernstein, D., Clayton, T., Clemmensen, P., Coste, P., Deliargyris, E.N., Eggink, G.J., et al., Goldstein, P., Grunsven, P. van, Hamm, C.W., Hamon, M., Hof, A. van't, Huber, K., Lapostolle, F., Nef, H., Nibbe, L., Orto, M. Campo dell', Pocock, S., Prats, J., Schuette, D., Soulat, L., Steg, P.G., Steinmetz, J., Verheugt, F.W.A., Zeymer, U.   +25 more
core   +1 more source

Temporal trends in the pre-procedural TIMI flow grade among patients with ST- segment elevation myocardial infarction – From the ACSIS registry

International Journal of Cardiology: Heart & Vasculature, 2021
Background: Pre-procedural TIMI coronary flow grade in patients with ST segment elevation myocardial infarction (STEMI) is associated with adverse clinical outcomes. There have been great advances in pharmacologic and invasive treatment of STEMI patients
Nili Schamroth Pravda, Tal Cohen, Robert Klempfner, Ran Kornowski, Roy Beigel, Katia Orvin, Merry Abitbol, Miri Schamroth Pravda, Idit Dobrecky-Mery, Ronen Rubinshtein, Madji Saada, Alon Eisen   +11 more
doaj   +1 more source

Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial.

European Heart Journal, 2019
AIMS To investigate the relationship between body mass index (BMI) and outcomes in patients with atrial fibrillation (AF). METHODS AND RESULTS In the ENGAGE AF-TIMI 48 trial, patients with AF were randomized to warfarin (international normalized ratio ...
G. Boriani, C. Ruff, J. Kuder, M. Shi, H. Lanz, H. Rutman, M. Mercuri, E. Antman, E. Braunwald, R. Giugliano   +9 more
semanticscholar   +1 more source

Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48

Circulation, 2019
Background: The ABC (age, biomarker, clinical history)-stroke and ABC-bleeding risk scores incorporate clinical variables and cardiovascular biomarkers to estimate risk of stroke or systemic embolic events and bleeding, respectively, in patients with ...
D. Berg, C. Ruff, P. Jarolím, R. Giugliano, F. Nordio, H. Lanz, M. Mercuri, E. Antman, E. Braunwald, D. Morrow   +9 more
semanticscholar   +1 more source

Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 Trial

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundWe studied the concomitant use of single antiplatelet therapy (SAPT) on the efficacy and safety of the anti‐Xa agent edoxaban in patients with atrial fibrillation (AF). Methods and ResultsENGAGE AF‐TIMI 48 was a randomized trial that compared 2
Haiyan Xu, Christian T. Ruff, Robert P. Giugliano, Sabina A. Murphy, Francesco Nordio, Indravadan Patel, Minggao Shi, Michele Mercuri, Elliott M. Antman, Eugene Braunwald   +9 more
doaj   +1 more source

Validity of TIMI Score for Predicting 14-Day Mortality of Non-ST Elevation Myocardial Infarction Patients

Cureus, 2021
Background Accurate management of non-ST elevation myocardial infarction (NSTEMI) patients can be achieved by stratifying risks as early as possible on hospital admission.
Dileep Kumar, T. Saghir, M. Zahid, Arti Ashok, Mukesh Kumar, Arshad Ali Shah, Izza Shahid, Sajjad Ali, Ayema Haque, M. Karim   +9 more
semanticscholar   +1 more source

Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background Cystatin C (Cys‐C) is a marker of renal function that has shown prognostic value for cardiovascular risk stratification across different patient populations.
Simon Correa, David A. Morrow, Eugene Braunwald, Richard Y. Davies, Erica L. Goodrich, Sabina A. Murphy, Christopher P. Cannon, Michelle L. O'Donoghue   +7 more
doaj   +1 more source

Early exclusion of major adverse cardiac events in emergency department chest pain patients: A prospective observational study [PDF]

, 2017
Background The current evaluation of patients with chest pain presenting to an emergency department (ED) with suspected acute coronary syndrome (ACS) is a lengthy process involving serial measurements of troponin.
Ahuja, Anil Tejbhan, Chan, Cangel Pui-yee, Cheng, Nga-man, Graham, Colin Alexander, Lee, Anna, Leung, Yuk-ki, Rainer, Timothy Hudson, Wong, Jeffrey Ka-tak, Yan, Bryan Ping-yen   +8 more
core   +2 more sources

Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF‐TIMI 48 Trial

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundDigoxin is widely used in patients with atrial fibrillation despite the lack of randomized controlled trials. Observational studies report conflicting results regarding its association with mortality, perhaps because of residual confounding by ...
Alon Eisen, Christian T. Ruff, Eugene Braunwald, Rose A. Hamershock, Basil S. Lewis, Christian Hassager, Tze‐Fan Chao, Jean Yves Le Heuzey, Michele Mercuri, Howard Rutman, Elliott M. Antman, Robert P. Giugliano   +11 more
doaj   +1 more source

Plasma Omega‐3 Fatty Acids and the Risk of Cardiovascular Events in Patients After an Acute Coronary Syndrome in MERLIN‐TIMI 36

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Plasma omega‐3 polyunsaturated fatty acids (ω3‐PUFAs) have been shown to be inversely correlated with the risk of cardiovascular death in primary prevention.
Thomas A. Zelniker, David A. Morrow, Benjamin M. Scirica, Jeremy D. Furtado, Jianping Guo, Dariush Mozaffarian, Marc S. Sabatine, Michelle L. O’Donoghue   +7 more
doaj   +1 more source